vendredi 7 décembre 2018

Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors

Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors. Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors

Aucun commentaire:

Enregistrer un commentaire